February 3, 2024

ECOG-ACRIN pays tribute to Edith Mitchell, MD

August 25, 2023

The July/August 2023 News from ECOG-ACRIN blog is now available

July 20, 2023

Dr. Pamela Kunz on what’s next after the successful E2211 trial for patients with neuroendocrine tumors

May 31, 2023

Your daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG

June 7, 2022

Pancreatic neuroendocrine tumors: Capecitabine plus temozolomide gives longer PFS than temozolomide alone

June 6, 2022

Novel drug combination demonstrates promising results in treating pancreatic neuroendocrine tumors

June 6, 2022

E2211: Dr. Pamela Kunz discusses the trial results and talks about the challenges of managing endocrine tumors

June 5, 2022

Dr. Pamela Kunz on pancreatic neuroendocrine tumors: A final analysis of temozolomide or temozolomide plus capecitabine

June 5, 2022

Drug combination shows promise for treating pancreatic neuroendocrine tumors

ECOG-ACRIN Cancer Research Group